{"id":"statin-simvastatin","safety":{"commonSideEffects":[{"rate":"1-3","effect":"Myalgia (muscle pain)"},{"rate":"1-3","effect":"Elevated liver enzymes (ALT/AST)"},{"rate":"2-5","effect":"Headache"},{"rate":"<0.1","effect":"Rhabdomyolysis (rare)"},{"rate":"1-2","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Simvastatin competitively binds to HMG-CoA reductase and blocks the conversion of HMG-CoA to mevalonate, a critical early step in the cholesterol biosynthetic pathway. This leads to decreased intracellular cholesterol production, upregulation of LDL receptors on hepatocytes, and increased clearance of LDL cholesterol from the bloodstream. The net result is a significant reduction in serum LDL cholesterol and triglycerides, with modest increases in HDL cholesterol.","oneSentence":"Simvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:41.987Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia"},{"name":"Primary prevention of cardiovascular disease in high-risk patients"},{"name":"Secondary prevention of cardiovascular events in patients with established coronary heart disease"}]},"trialDetails":[{"nctId":"NCT02968810","phase":"PHASE2","title":"Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-06-21","conditions":"Cirrhosis, Hepatocellular Carcinoma","enrollment":52},{"nctId":"NCT07392541","phase":"PHASE1, PHASE2","title":"Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2026-01-30","conditions":"Advanced Biliary Tract Carcinoma","enrollment":29},{"nctId":"NCT07459972","phase":"PHASE4","title":"Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-03-15","conditions":"Liver Cirrhosis, Portal Hypertension Related to Cirrhosis","enrollment":22},{"nctId":"NCT05586360","phase":"PHASE2","title":"T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-03-11","conditions":"Prostate Cancer","enrollment":36},{"nctId":"NCT07389304","phase":"PHASE1","title":"[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Lipid Profile,Blood Pressure","enrollment":100},{"nctId":"NCT04457089","phase":"EARLY_PHASE1","title":"Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer","status":"COMPLETED","sponsor":"Marc Goodman","startDate":"2021-01-25","conditions":"Recurrent Ovarian Cancer, Platinum-sensitive Ovarian Cancer","enrollment":18},{"nctId":"NCT07378293","phase":"PHASE1","title":"Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Diabete Mellitus, Lipid Profile","enrollment":100},{"nctId":"NCT06553157","phase":"PHASE1, PHASE2","title":"Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy","status":"COMPLETED","sponsor":"Minia University","startDate":"2024-09-01","conditions":"Solid Tumors, Ototoxicity","enrollment":56},{"nctId":"NCT07307989","phase":"PHASE2","title":"Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-08-01","conditions":"Ischemic Stroke, Hypercholesteremia","enrollment":300},{"nctId":"NCT06501443","phase":"PHASE4","title":"LATAM LOWERS LDL-C","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-11","conditions":"Hypercholesterolaemia","enrollment":520},{"nctId":"NCT07102979","phase":"NA","title":"Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response","status":"ENROLLING_BY_INVITATION","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-09-01","conditions":"Liver Cirrhosis","enrollment":150},{"nctId":"NCT06858332","phase":"","title":"Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-04-15","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":2382},{"nctId":"NCT03896217","phase":"PHASE2","title":"Simvastatin in Secondary Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"University College, London","startDate":"2019-05-16","conditions":"Secondary Progressive Multiple Sclerosis","enrollment":40},{"nctId":"NCT06856772","phase":"PHASE4","title":"Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial","status":"NOT_YET_RECRUITING","sponsor":"Tor Biering-Sørensen","startDate":"2025-02-28","conditions":"Cardiovascular Diseases (CVD), Drug Effect, Atherosclerosis Cardiovascular Disease","enrollment":42000},{"nctId":"NCT03127631","phase":"NA","title":"A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients","status":"RECRUITING","sponsor":"McMaster University","startDate":"2015-10-21","conditions":"Prostate Cancer, Cardiovascular Disease","enrollment":6000},{"nctId":"NCT06785740","phase":"","title":"Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-11-01","conditions":"Ischemic Stroke, TIA","enrollment":300},{"nctId":"NCT06785727","phase":"PHASE4","title":"StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Prof. dr. Nathalie van der Velde","startDate":"2025-02-01","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":612},{"nctId":"NCT06523465","phase":"PHASE4","title":"Statin Combined with Amlodipine Treats Primary Aldosteronism","status":"RECRUITING","sponsor":"Third Military Medical University","startDate":"2024-09-10","conditions":"Primary Aldosteronism, Statin, Mineralocorticoid Receptor Antagonist","enrollment":180},{"nctId":"NCT06684366","phase":"","title":"Chronic Coronary Syndrome Real Practice and Guidelines","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assiut University","startDate":"2024-10-22","conditions":"Coronary Arterial Disease (CAD)","enrollment":300},{"nctId":"NCT01414192","phase":"","title":"A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-11-15","conditions":"Dyslipidemia, Hypercholesterolemia","enrollment":3215},{"nctId":"NCT00652717","phase":"PHASE4","title":"Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-02-01","conditions":"Cardiovascular Disorder","enrollment":280},{"nctId":"NCT00132717","phase":"PHASE3","title":"A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-01-01","conditions":"Hypercholesterolemia","enrollment":450},{"nctId":"NCT00166530","phase":"PHASE4","title":"EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-11","conditions":"Atherosclerosis","enrollment":367},{"nctId":"NCT00395603","phase":"PHASE3","title":"Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Cardiovascular Diseases, Diabetes Mellitus","enrollment":550},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT02096588","phase":"PHASE2","title":"Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2014-05-20","conditions":"Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer","enrollment":34},{"nctId":"NCT00653523","phase":"PHASE3","title":"Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia (P05457)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-12-01","conditions":"Hypercholesterolemia","enrollment":151},{"nctId":"NCT00479713","phase":"PHASE3","title":"A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02-01","conditions":"Hypercholesterolemia","enrollment":618},{"nctId":"NCT00862251","phase":"PHASE3","title":"Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2009-04","conditions":"Cardiovascular Disorder, Diabetes Mellitus","enrollment":808},{"nctId":"NCT05285085","phase":"","title":"Real World Evidence Study of Statin Use in Brazil","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2021-11-19","conditions":"Cardiovascular Diseases, Myocardial Infarction, Stroke","enrollment":2133900},{"nctId":"NCT03882905","phase":"PHASE3","title":"A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-01-31","conditions":"Primary Hypercholesterolemia","enrollment":769},{"nctId":"NCT06338241","phase":"PHASE4","title":"Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model","status":"RECRUITING","sponsor":"Mario Pérez Sayáns","startDate":"2024-03-02","conditions":"Bone Loss, Regenerative Inflammation","enrollment":30},{"nctId":"NCT01764451","phase":"EARLY_PHASE1","title":"Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins","status":"TERMINATED","sponsor":"University of New Mexico","startDate":"2012-03","conditions":"Cavernous Angioma, Familial, Cerebral Cavernous Malformations, Cerebral Cavernous Hemangioma","enrollment":12},{"nctId":"NCT06273111","phase":"EARLY_PHASE1","title":"Topical Simvastatin for Treating Infantile Hemangioma","status":"UNKNOWN","sponsor":"Joyce Teng","startDate":"2024-04-01","conditions":"Hemangioma Skin","enrollment":12},{"nctId":"NCT01563731","phase":"PHASE4","title":"Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2013-04","conditions":"Stroke, Transient Ischemic Attack, Hypertension","enrollment":200},{"nctId":"NCT06262685","phase":"PHASE4","title":"Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins","status":"UNKNOWN","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2024-03-04","conditions":"Cardiovascular Diseases, Dyslipidemias, Statin Adverse Reaction","enrollment":216},{"nctId":"NCT00587717","phase":"NA","title":"The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2002-09","conditions":"Carotid Artery Disease","enrollment":35},{"nctId":"NCT00743197","phase":"NA","title":"Women With Chest Pain and Normal Coronary Arteries Study","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2008-05","conditions":"Chest Pain","enrollment":3},{"nctId":"NCT01326676","phase":"PHASE3","title":"Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial","status":"WITHDRAWN","sponsor":"Imperial College London","startDate":"2011-02","conditions":"Cardiovascular Disease","enrollment":""},{"nctId":"NCT06016218","phase":"PHASE1, PHASE2","title":"Effect of Local Application of Simvastatin Versus Bone Powder on Implant Bone Changes","status":"COMPLETED","sponsor":"British University In Egypt","startDate":"2021-01-05","conditions":"Dental Caries Extending to Pulp, Dental Implant Failed","enrollment":24},{"nctId":"NCT03454529","phase":"PHASE2","title":"The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer","status":"COMPLETED","sponsor":"Michael Simon","startDate":"2018-03-09","conditions":"Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7","enrollment":24},{"nctId":"NCT02713945","phase":"PHASE3","title":"Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2017-01-25","conditions":"Noonan Syndrome","enrollment":53},{"nctId":"NCT00655993","phase":"PHASE1","title":"Effect of Statin Therapy on C-reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)","status":"COMPLETED","sponsor":"VA Loma Linda Health Care System","startDate":"2008-04","conditions":"COPD, Inflammation","enrollment":30},{"nctId":"NCT01653223","phase":"NA","title":"Myocardial Protection Effect of Simvastatin Undergoing Cardiac Surgery","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2013-01","conditions":"Congenital Heart Disease, Heart Valve Disease","enrollment":369},{"nctId":"NCT02511418","phase":"NA","title":"Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"","conditions":"Hyperlipidemia, Hypertension, Chronic Renal Failure","enrollment":""},{"nctId":"NCT02534376","phase":"EARLY_PHASE1","title":"Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2015-09","conditions":"Prostate Cancer","enrollment":63},{"nctId":"NCT04507373","phase":"PHASE4","title":"7T Magnetic Resonance Spectroscopy and Skeletal Muscle Biopsy Findings in Statin Associated Adverse Muscle Events","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-08-17","conditions":"Muscle Cramp, Ache, Weakness, Muscle","enrollment":3},{"nctId":"NCT02188121","phase":"PHASE4","title":"Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2015-02","conditions":"Serious Mental Illness, Schizophrenia, Schizoaffective Disorder","enrollment":227},{"nctId":"NCT05658692","phase":"PHASE4","title":"Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-10-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":1000},{"nctId":"NCT02743364","phase":"PHASE2","title":"Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2016-09-19","conditions":"Acute Pancreatitis","enrollment":8},{"nctId":"NCT05613400","phase":"PHASE4","title":"Statin and Bone Health","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-04-13","conditions":"Diabetes Mellitus, Type 2","enrollment":240},{"nctId":"NCT01763866","phase":"PHASE3","title":"LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2","status":"COMPLETED","sponsor":"Amgen","startDate":"2013-01-15","conditions":"Hyperlipidemia","enrollment":2067},{"nctId":"NCT02850081","phase":"PHASE3","title":"Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-06-01","conditions":"Carotid Artery Stenosis, Strokes","enrollment":31},{"nctId":"NCT04575090","phase":"NA","title":"7 Tesla MRI Study in Patients With Statin Related Muscle Complaints","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2016-03-05","conditions":"Statin-related Muscle Pain, Muscle Aches, Muscle Weakness","enrollment":8},{"nctId":"NCT05582317","phase":"NA","title":"Efficacy of Combination of Biodentine and Simvastatin as a Pulp Capping Materials in Vital Pulpotomy of Primary Molars","status":"COMPLETED","sponsor":"Suez Canal University","startDate":"2021-05-23","conditions":"Pulpitis - Irreversible","enrollment":20},{"nctId":"NCT02871687","phase":"PHASE1","title":"Effect of Statin Use on Aldosterone Secretion","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2016-04","conditions":"Healthy Subjects","enrollment":103},{"nctId":"NCT01715714","phase":"PHASE4","title":"Statin Recapture Therapy Before Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2012-11-07","conditions":"Coronary Artery Disease","enrollment":2630},{"nctId":"NCT02246257","phase":"NA","title":"Early Rheumatoid Arthritis COR Intervention","status":"UNKNOWN","sponsor":"MD, PhD, Annemarie Lyng Svensson","startDate":"2014-09","conditions":"Rheumatoid Arthritis, Cardiovascular Diseases","enrollment":300},{"nctId":"NCT00231803","phase":"NA","title":"The Canadian Prevention of Renal and Cardiovascular Endpoints Trial","status":"COMPLETED","sponsor":"Brendan Barrett","startDate":"2005-04","conditions":"Chronic Kidney Disease","enrollment":474},{"nctId":"NCT01047501","phase":"PHASE3","title":"Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2009-12","conditions":"Hypertriglyceridemia","enrollment":702},{"nctId":"NCT01047683","phase":"PHASE3","title":"Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2009-12","conditions":"Hypertriglyceridemia","enrollment":229},{"nctId":"NCT01492361","phase":"PHASE3","title":"A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2011-11","conditions":"Cardiovascular Diseases","enrollment":8179},{"nctId":"NCT02871934","phase":"NA","title":"Integrating Pharmacogenetics In Clinical Care","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2016-08-01","conditions":"Cardiovascular Disease","enrollment":408},{"nctId":"NCT01587235","phase":"PHASE4","title":"A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2013-03","conditions":"Dyslipidemia","enrollment":""},{"nctId":"NCT00730132","phase":"","title":"Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-01","conditions":"Coronary Heart Disease, Hypercholesterolemia","enrollment":712},{"nctId":"NCT05230472","phase":"PHASE4","title":"Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-01-01","conditions":"VAP - Ventilator Associated Pneumonia","enrollment":161},{"nctId":"NCT00724477","phase":"","title":"Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-10","conditions":"Primary Hypercholesterolemia","enrollment":1663},{"nctId":"NCT00652327","phase":"PHASE4","title":"Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-12","conditions":"Hypercholesterolemia","enrollment":83},{"nctId":"NCT05072405","phase":"PHASE4","title":"The Interaction of Herbs and Statins","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2013-01-11","conditions":"Drug Interaction","enrollment":38},{"nctId":"NCT02490527","phase":"NA","title":"Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2015-06","conditions":"Statin Intolerance","enrollment":19},{"nctId":"NCT04921657","phase":"","title":"Genome-wide Analysis of Lipid-lowering Efficacy and Drug Level of Simvastatin and Rosuvastatin","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2014-11","conditions":"Hypercholesterolemia","enrollment":362},{"nctId":"NCT03435744","phase":"PHASE3","title":"Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.","status":"COMPLETED","sponsor":"Pakistan Institute of Living and Learning","startDate":"2019-01-01","conditions":"Treatment Resistant Depression, Major Depressive Disorder","enrollment":150},{"nctId":"NCT03355027","phase":"NA","title":"Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease","status":"UNKNOWN","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2017-11-30","conditions":"Atherosclerosis, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT02714569","phase":"PHASE1","title":"A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2016-03","conditions":"Dyslipidemias","enrollment":60},{"nctId":"NCT04829149","phase":"","title":"Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2016-06-14","conditions":"Dyslipidemias","enrollment":5717},{"nctId":"NCT04824898","phase":"PHASE1","title":"The Use of Injectable Plasma Versus the Use of Simvastatin Gel in Surgical Management of Bony Defect in Dentistry","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2021-01-20","conditions":"Intra-bony Pockets","enrollment":24},{"nctId":"NCT00673660","phase":"","title":"Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-10","conditions":"Dyslipidemia","enrollment":375},{"nctId":"NCT01304641","phase":"","title":"Cardiovascular Events Based On Statin Initiation In The Elderly","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-11","conditions":"Cardiovascular, Dyslipidemia","enrollment":31603},{"nctId":"NCT02796378","phase":"PHASE4","title":"Living With Statins - Interventional Exercise Study","status":"UNKNOWN","sponsor":"University of Copenhagen","startDate":"2016-06","conditions":"Cardiovascular Disease, Diabetes Mellitus","enrollment":30},{"nctId":"NCT04301336","phase":"PHASE2, PHASE3","title":"Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2019-11-01","conditions":"Vaso-occlusive Crisis, Sickle Cell Disease, Sickle Cell Anemia in Children","enrollment":350},{"nctId":"NCT01859455","phase":"PHASE1","title":"Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-07","conditions":"Hypercholesterolemia, LDL Cholesterol","enrollment":25},{"nctId":"NCT01106495","phase":"NA","title":"Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2010-05","conditions":"Atherosclerosis","enrollment":150},{"nctId":"NCT01382472","phase":"PHASE4","title":"Microcirculation In Acute Coronary Syndromes","status":"COMPLETED","sponsor":"Helse Stavanger HF","startDate":"2011-09","conditions":"ST Elevation (STEMI) Myocardial Infarction","enrollment":25},{"nctId":"NCT00879710","phase":"NA","title":"Effect of Diabetes Mellitus on Cholesterol Metabolism","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2008-08","conditions":"Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Hypercholesterolemia","enrollment":57},{"nctId":"NCT03653663","phase":"PHASE4","title":"NIRS to Diagnose SAMS","status":"UNKNOWN","sponsor":"Hartford Hospital","startDate":"2018-01-01","conditions":"Statin Adverse Reaction, Skeletal Myopathy","enrollment":40},{"nctId":"NCT00687076","phase":"PHASE4","title":"Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2004-04","conditions":"Peripheral Arterial Disease","enrollment":102},{"nctId":"NCT00842920","phase":"PHASE4","title":"Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2008-12","conditions":"Mild Cognitive Impairment","enrollment":520},{"nctId":"NCT04140201","phase":"PHASE4","title":"Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients","status":"UNKNOWN","sponsor":"Alaa Hassan ElBaz","startDate":"2020-02","conditions":"Diabetic Retinopathy","enrollment":80},{"nctId":"NCT04177173","phase":"PHASE4","title":"Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid Arthritis","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2017-09-01","conditions":"Arthritis, Rheumatoid","enrollment":100},{"nctId":"NCT02715726","phase":"PHASE3","title":"Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-07-27","conditions":"Hypercholesterolemia","enrollment":615},{"nctId":"NCT01890967","phase":"PHASE2","title":"A Study of LY3015014 in Participants With High Cholesterol","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-06","conditions":"Hypercholesterolemia","enrollment":527},{"nctId":"NCT00180713","phase":"PHASE1, PHASE2","title":"Simvastatin as a Treatment for Pulmonary Hypertension","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2005-10","conditions":"Pulmonary Hypertension","enrollment":42},{"nctId":"NCT04061824","phase":"PHASE4","title":"Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2016-05-24","conditions":"Hypertension, Dyslipidemias","enrollment":150},{"nctId":"NCT03971019","phase":"PHASE3","title":"Survival Benefits of Statins in Breast Cancer Patients","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-03-28","conditions":"Breast Cancer Female","enrollment":314},{"nctId":"NCT00939822","phase":"PHASE2","title":"Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2009-03","conditions":"Alzheimer's Disease","enrollment":88},{"nctId":"NCT01047423","phase":"PHASE4","title":"Targeting Microvascular Dysfunction in Young Hypertensive Patients","status":"WITHDRAWN","sponsor":"Queen's University, Belfast","startDate":"2009-08","conditions":"Hypertension","enrollment":""},{"nctId":"NCT02285738","phase":"EARLY_PHASE1","title":"Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2014-12-30","conditions":"Solid Tumor, Cancer","enrollment":17},{"nctId":"NCT01813994","phase":"NA","title":"Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2014-11","conditions":"Early Gastric Cancer or Gastric Adenoma","enrollment":96},{"nctId":"NCT02072161","phase":"PHASE2","title":"Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy","status":"COMPLETED","sponsor":"Esperion Therapeutics, Inc.","startDate":"2014-03","conditions":"Hypercholesterolemia","enrollment":133},{"nctId":"NCT00486044","phase":"PHASE2","title":"Evaluating Simvastatin's Potential Role in Therapy","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2005-02","conditions":"Alzheimer Disease","enrollment":103}],"_emaApprovals":[],"_faersSignals":[{"count":4,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":3,"reaction":"DIARRHOEA"},{"count":3,"reaction":"DRUG INEFFECTIVE"},{"count":3,"reaction":"FALL"},{"count":3,"reaction":"HEADACHE"},{"count":3,"reaction":"PAIN IN EXTREMITY"},{"count":2,"reaction":"ARTHRALGIA"},{"count":2,"reaction":"CARDIAC DISORDER"},{"count":2,"reaction":"CHEST PAIN"},{"count":2,"reaction":"EXTRA DOSE ADMINISTERED"}],"_approvalHistory":[],"publicationCount":76,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Statin (simvastatin)","genericName":"Statin (simvastatin)","companyName":"University of Aarhus","companyId":"university-of-aarhus","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Simvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels. Used for Hypercholesterolemia, Primary prevention of cardiovascular disease in high-risk patients, Secondary prevention of cardiovascular events in patients with established coronary heart disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}